Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K F Wagner

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|January 1, 1992
Abnormalities of morning serum cortisol levels and circadian rhythms of CD4+ lymphocyte counts in human immunodeficiency virus type 1-infected adult patientsJ L Malone, E C Oldfield, K F Wagner, et al.
International Journal of Dermatology|June 1, 1995
Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Military Medical Consortium for the Advancement of Retroviral research (MMCARR)J Lindstrom, K J Smith, H G Skelton, et al.
Journal of the American Academy of Dermatology|August 1, 1993
Immunohistochemical features in inflammatory linear verrucous epidermal nevi suggest a distinctive pattern of clonal dysregulation of growth. Military Medical Consortium for the Advancement of Retroviral ResearchM L Welch, K J Smith, H G Skelton, et al.
Annals of Internal Medicine|June 1, 1980
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trialW E Stamm, G W Counts, K F Wagner, et al.
Journal of the American Academy of Dermatology|February 1, 1993
Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral ResearchK J Smith, H G Skelton, J Yeager, et al.
International Journal of Dermatology|November 1, 1993
Helistat absorbable collagen hemostatic sponges in cutaneous surgery in HIV-1+ patients. Military Medical Consortium for the Advancement of Military Medicine (MMCAR)H G Skelton, K J Smith, G Turiansky, et al.
Journal of Cutaneous Medicine and Surgery|May 19, 1998
Lymphoid markers, activation markers, and adhesion molecules in cutaneous biopsy specimens from HIV+ patients with disease progression. The Military Medical Consortium for the Advancement of Retroviral ResearchK J Smith, H G Skelton, J Yeager, et al.
AIDS (London, England)|September 26, 1997
Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individualsT P Le, D R Tribble, S Y Zhou, et al.
Journal of Virology|March 1, 1997
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell functionR A McDonald, D L Mayers, R C Chung, et al.
The British Journal of Dermatology|July 17, 1998
Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?K J Smith, T L Barrett, R Neafie, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|January 1, 1992
Abnormalities of morning serum cortisol levels and circadian rhythms of CD4+ lymphocyte counts in human immunodeficiency virus type 1-infected adult patientsJ L Malone, E C Oldfield, K F Wagner, et al.
International Journal of Dermatology|June 1, 1995
Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Military Medical Consortium for the Advancement of Retroviral research (MMCARR)J Lindstrom, K J Smith, H G Skelton, et al.
Journal of the American Academy of Dermatology|August 1, 1993
Immunohistochemical features in inflammatory linear verrucous epidermal nevi suggest a distinctive pattern of clonal dysregulation of growth. Military Medical Consortium for the Advancement of Retroviral ResearchM L Welch, K J Smith, H G Skelton, et al.
Annals of Internal Medicine|June 1, 1980
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trialW E Stamm, G W Counts, K F Wagner, et al.
Journal of the American Academy of Dermatology|February 1, 1993
Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral ResearchK J Smith, H G Skelton, J Yeager, et al.
International Journal of Dermatology|November 1, 1993
Helistat absorbable collagen hemostatic sponges in cutaneous surgery in HIV-1+ patients. Military Medical Consortium for the Advancement of Military Medicine (MMCAR)H G Skelton, K J Smith, G Turiansky, et al.
Journal of Cutaneous Medicine and Surgery|May 19, 1998
Lymphoid markers, activation markers, and adhesion molecules in cutaneous biopsy specimens from HIV+ patients with disease progression. The Military Medical Consortium for the Advancement of Retroviral ResearchK J Smith, H G Skelton, J Yeager, et al.
AIDS (London, England)|September 26, 1997
Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individualsT P Le, D R Tribble, S Y Zhou, et al.
Journal of Virology|March 1, 1997
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell functionR A McDonald, D L Mayers, R C Chung, et al.
The British Journal of Dermatology|July 17, 1998
Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?K J Smith, T L Barrett, R Neafie, et al.
Pageof 8